Hormone Helps Protect Liver from Inflammation Without Weight Loss

Topic: Health

Researchers at McMaster University found that a hormone called GDF15 helps protect the liver from inflammation. This discovery could lead to new treatments for advanced fatty liver disease.

Scientists at McMaster University have made an exciting discovery about a hormone called GDF15. They found that it not only helps with weight loss, but also protects the liver from inflammation. This is important because many people around the world suffer from a condition called metabolic dysfunction-associated steatohepatitis (MASH), which can lead to serious health problems like cirrhosis and liver cancer.

The researchers used special mouse models to study how GDF15 works. They found that it sends a signal from the brain to the liver, which helps reduce inflammation. This is a new way of thinking about GDF15, as previously it was only known for its role in weight loss.

GDF15 also slows down the buildup of scar tissue in the liver, which can happen when liver disease gets worse. The researchers believe that this hormone could be part of the body's natural defense system against chronic liver injury. This is a promising finding, as it could lead to new treatments for advanced fatty liver disease.

The study was published in Cell Metabolism on August 10, 2026. It challenges the idea that GDF15's benefits are only related to weight loss and appetite regulation.

Why It Matters

This discovery is important because it could lead to new treatments for advanced fatty liver disease, which affects millions of people worldwide. It also shows how a hormone can have multiple roles in the body, which could lead to new areas of research.

Key Facts

• GDF15 is a hormone that helps protect the liver from inflammation.
• The researchers used mouse models to study how GDF15 works.
• GDF15 sends a signal from the brain to the liver to reduce inflammation.
• GDF15 slows down the buildup of scar tissue in the liver.
• The study was published in Cell Metabolism on August 10, 2026.

Key Terms

Metabolic dysfunction-associated steatohepatitis (MASH)

A condition where there is inflammation and scarring of the liver due to excess fat.

Implications

This discovery is important because it could lead to new treatments for advanced fatty liver disease, which affects millions of people worldwide. It also shows how a hormone can have multiple roles in the body, which could lead to new areas of research.